Altamira Therapeutics Ltd. (CYTO) Financials
CYTO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-06-30 | 6.9 million | 8.9 million |
| 2023-03-31 | 6.9 million | 16.0 million |
| 2022-12-31 | 6.8 million | 15.8 million |
| 2022-09-30 | 6.5 million | 15.0 million |
CYTO Free Cash Flow and Stock based compensation
No data available :(
CYTO Net Income
No data available :(
CYTO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-06-30 | 55138 | - | 451655 |
| 2023-03-31 | 16843 | - | - |
| 2022-12-31 | - | - | 499134 |
| 2022-09-30 | 15786 | - | - |
CYTO Shares Outstanding
CYTO Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-06-30 | - | 2.8 million | - | - |
| 2023-03-31 | - | - | - | - |
| 2022-12-31 | - | - | - | - |
| 2022-09-30 | - | - | - | - |
CYTO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-06-30 | 128631 | 331530 |
| 2023-03-31 | - | - |
| 2022-12-31 | - | - |
| 2022-09-30 | - | - |
CYTO
Price: $1.64
52 week price:
Earnings Per Share: -439.97 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 22400
Market Capitalization: 3.6 million